Clinical Trial Update: Bethanechol for Eosinophilic Esophagitis [Phase 2]

View source ↗

Summary

Phase 2 trial of bethanechol for eosinophilic esophagitis was terminated with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• Bethanechol (bethanechol)

Snippet

Sponsor: University of Iowa | Conditions: Eosinophilic Esophagitis (EoE) | Phase 2 | Status: TERMINATED | Results posted: 2016-04-22